BrightSpring Health price target raised to $45 from $42 at Mizuho

Mizuho analyst Ann Hynes raised the firm’s price target on BrightSpring Health (BTSG) to $45 from $42 and keeps an Outperform rating on the shares. The firm updated targets in the healthcare facilities and managed care group as part of a Q4 preview. Mizuho’s physician survey indicated healthcare utilization growth trends decelerated sequentially despite easier year-over-year comps, which could indicate trend is peaking, the analyst tells investors in a research note.